9 spine, orthopedic medtech acquisitions in 2024

Spinal Tech

In 2024, several spine and orthopedic medtech companies banded together through acquisition deals.

1. Enovis completed its acquisition of LimaCorporate in January. LimaCorporate will add to Enovis' orthopedic reconstruction market with products including the Trabecular Titanium implants and shoulder revision devices.

2. RTI Surgical acquired Cook Biotech in January. The acquisition will bolster RTI Surgical's place as a contract development and manufacturing organization in regenerative medicine. 

3. Stryker completed its acquisition of Serf SaS in March. Serf SaS is a hip implant company and is behind the Dual Mobility Cup.

4. Stryker completed its acquisition of Artelon, a company that develops soft tissue fixation products for sports medicine and foot and ankle procedures.

5. Zimmer Biomet signed a definitive agreement to acquire OrthoGrid Systems. OrthoGrid Systems develops artificial intelligence-driven guidance for total hip replacement. The acquisition includes Hip AI and two more FDA-cleared orthopedic applications and more than 40 patents.

6. Stryker completed its acquisition of care.ai, a virtual care company. The acquisition will bolster Stryker's healthcare IT offerings and its wireless medical device portfolio. Care.ai develops artificial intelligence-assisted virtual care workflows and smart room technology. 

7. Stryker acquired Vertos Medical, a pain management company. Vertos Medical focuses on treating chronic lower back pain from lumbar spinal stenosis and is behind the Mild procedure. 

8. Stryker completed its acquisition of Nico Corp., a company focused on minimally invasive tumor and intracerebral hemorrhage procedures. The acquisition expands Stryker's neurosurgery portfolio, adding Nico's BrainPath and Myriad products.

9. RTI Surgical, a contract development and manufacturing organization, plans to acquire Collagen Solutions. Collagen Solutions is a global supplier of collagen and xenograft tissue for orthopedics, sports medicine and cardiology. The acquisition expands RTI's soft tissue portfolio and the potential to accelerate products.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Webinars

Featured Whitepapers